Divis Laboratories (India) Today
| DIVISLAB | 6,173 220.90 3.71% |
Performance15 of 100
| Odds Of DistressLess than 9
|
Divis Laboratories is trading at 6172.70 as of the 2nd of December 2024, a 3.71 percent increase since the beginning of the trading day. The stock's open price was 5951.8. Divis Laboratories has less than a 9 % chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. Equity ratings for Divis Laboratories Limited are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of September 2024 and ending today, the 2nd of December 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Divis Laboratories is entity of India. It is traded as Stock on NSE exchange. The company has 265.47 M outstanding shares. More on Divis Laboratories Limited
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Divis Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Divis Laboratories' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Divis Laboratories or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors) | ||||
Divis Laboratories' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Divis Laboratories' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsDivis Laboratories can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Divis Laboratories' financial leverage. It provides some insight into what part of Divis Laboratories' total assets is financed by creditors.
| |||||
Divis Laboratories Limited (DIVISLAB) is traded on National Stock Exchange of India in India and employs 9,741 people. Divis Laboratories is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a current market capitalization of 1.64 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Divis Laboratories's market, we take the total number of its shares issued and multiply it by Divis Laboratories's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Divis Laboratories operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 265.47 M outstanding shares.
Divis Laboratories Limited has accumulated about 1.41 B in cash with 12.61 B of positive cash flow from operations.
Check Divis Laboratories Probability Of Bankruptcy
Ownership AllocationDivis Laboratories holds a total of 265.47 Million outstanding shares. Divis Laboratories Limited retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Divis Ownership Details
Divis Laboratories Risk Profiles
Although Divis Laboratories' alpha and beta are two of the key measurements used to evaluate Divis Laboratories' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.06 | |||
| Semi Deviation | 0.5905 | |||
| Standard Deviation | 1.62 | |||
| Variance | 2.63 |
Divis Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Divis Laboratories without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
| All Next | Launch Module |
Divis Laboratories Corporate Management
Elected by the shareholders, the Divis Laboratories' board of directors comprises two types of representatives: Divis Laboratories inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Divis. The board's role is to monitor Divis Laboratories' management team and ensure that shareholders' interests are well served. Divis Laboratories' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Divis Laboratories' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Y BE | Global Head | Profile | |
| LLB MCom | VP Officer | Profile | |
| Madhusudana Divi | Director Director | Profile | |
| Srinivasa MPharm | Chief Technologist | Profile | |
| MPharm Pharm | CEO Director | Profile | |
| BTech MBA | Vice Marketing | Profile |
Other Information on Investing in Divis Stock
Divis Laboratories financial ratios help investors to determine whether Divis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Divis with respect to the benefits of owning Divis Laboratories security.